DE69736163D1 - Verfahren zur Expression von Polypeptide in Fishen durch wässerung in DNS enthaltende Lösung - Google Patents

Verfahren zur Expression von Polypeptide in Fishen durch wässerung in DNS enthaltende Lösung

Info

Publication number
DE69736163D1
DE69736163D1 DE69736163T DE69736163T DE69736163D1 DE 69736163 D1 DE69736163 D1 DE 69736163D1 DE 69736163 T DE69736163 T DE 69736163T DE 69736163 T DE69736163 T DE 69736163T DE 69736163 D1 DE69736163 D1 DE 69736163D1
Authority
DE
Germany
Prior art keywords
methods
aquaculture
fish
expression systems
polypeptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69736163T
Other languages
English (en)
Other versions
DE69736163T2 (de
Inventor
Heather L Davis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ottawa Health Research Institute
Original Assignee
Ottawa Health Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/740,805 external-priority patent/US5780448A/en
Application filed by Ottawa Health Research Institute filed Critical Ottawa Health Research Institute
Application granted granted Critical
Publication of DE69736163D1 publication Critical patent/DE69736163D1/de
Publication of DE69736163T2 publication Critical patent/DE69736163T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
DE69736163T 1996-11-04 1997-11-04 Verfahren zur Expression von Polypeptide in Fischen durch eintauchen in eine plasmid DNA enthaltende Lösung Expired - Lifetime DE69736163T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US740805 1996-11-04
US08/740,805 US5780448A (en) 1995-11-07 1996-11-04 DNA-based vaccination of fish
EP96117859A EP0773295B1 (de) 1995-11-07 1996-11-07 Verfahren zur Expression von Polypeptide in Fischen durch eintauchen in eine Plasmid DNS enthaltende Lösung
EP96117859 1996-11-07

Publications (2)

Publication Number Publication Date
DE69736163D1 true DE69736163D1 (de) 2006-08-03
DE69736163T2 DE69736163T2 (de) 2007-05-03

Family

ID=36686672

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69736163T Expired - Lifetime DE69736163T2 (de) 1996-11-04 1997-11-04 Verfahren zur Expression von Polypeptide in Fischen durch eintauchen in eine plasmid DNA enthaltende Lösung

Country Status (5)

Country Link
EP (1) EP0839913B1 (de)
AT (1) ATE331030T1 (de)
DE (1) DE69736163T2 (de)
ES (1) ES2268719T3 (de)
PT (1) PT839913E (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) * 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
EP1094069B2 (de) * 1999-10-18 2008-04-23 Intervet International BV DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
WO2001049712A2 (en) * 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
DE10317079A1 (de) * 2003-04-12 2005-02-03 Scheller, Albert, Dr. Speicher

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5076208A (en) * 1990-09-14 1991-12-31 Massachusetts Institute Of Technology Ultrasound-mediated administration of compounds into aquatic animals
US5512421A (en) * 1991-02-19 1996-04-30 The Regents Of The University Of California Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors
IT1256575B (it) * 1992-12-10 1995-12-11 Cesalpino Andrea Fond Procedimento per la preparazione di immunogeni costituiti da antigeni esogeni capaci di generare non solo la risposta immune dei linfociti t helper,ma anche una efficace risposta dei linfociti t citotossici; e immunogeni cosi' ottenibili.
FR2719316B1 (fr) * 1994-04-28 1996-05-31 Idm Nouveaux complexes d'acide nucléique et de polymère, leur procédé de préparation et leur utilisation pour la transfection de cellules.
WO1996003034A1 (en) * 1994-07-27 1996-02-08 Massachusetts Institute Of Technology Method for retroviral vector insertion in fish
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish

Also Published As

Publication number Publication date
DE69736163T2 (de) 2007-05-03
EP0839913A3 (de) 1999-06-16
ATE331030T1 (de) 2006-07-15
ES2268719T3 (es) 2007-03-16
EP0839913B1 (de) 2006-06-21
PT839913E (pt) 2006-09-29
EP0839913A2 (de) 1998-05-06

Similar Documents

Publication Publication Date Title
EP0773295A3 (de) Auf DNA beruhende Impfung von Fischen durch Wässerung
FI113969B (fi) Menetelmä CD40:n liukoisen ligandin valmistamiseksi, sitä koodaava nukleiinihappo ja sen käyttö
DE3382190D1 (de) Immunogener protein- oder peptidkomplex, verfahren zur herstellung dieses komplexes und seine verwendung als immunstimulans und als impfstoff.
ATE210151T1 (de) Peptide aus der sequenz des hpth (1-37)
ATA82487A (de) Verfahren zur rekombinanten herstellung eines proteins
ATE369144T1 (de) Verfahren zur steigerung des haarwuchses durch wnt polypeptid
DE58905979D1 (de) Verfahren zur aufzucht von wassertieren.
DE60310562D1 (de) Verfahren zur verstärkung einer immunantwort von nukleinsäureimpfungen
DE69434672D1 (de) Verfahren zur behandlung von hühnereiern
ATE411043T1 (de) Verfahren von dna-impfung
DE59008334D1 (de) Verfahren zur Präparierung von biologischem Implantationsmaterial.
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
ATE346083T1 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
ATE263836T1 (de) Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür
DE3786832D1 (de) Verfahren zur herstellung von immunoglobulinzubereitungen fuer intravenoese injektion.
ATE142694T1 (de) Neues verfahren zur produktion von nichtfusioniertem protein in e. coli
DE69736163D1 (de) Verfahren zur Expression von Polypeptide in Fishen durch wässerung in DNS enthaltende Lösung
DE69313556T2 (de) Verfahren zur Herstellung von zyklischen Depsipeptiden
ATE432287T1 (de) Peptidfragmente mit den zelltod verhindernder aktivität
DE68910771T2 (de) Verfahren zur Herstellung von verbessertem Proteinhydrolysat.
DE3785119T2 (de) Verfahren zur herstellung von aminosaeuren.
DE69013621T2 (de) Verfahren zur Herstellung von tertiärem Amino-Alkohol.
DE3886755T2 (de) Verfahren zur behandlung von gefässkrankheiten.
DE58908736D1 (de) Verfahren zur Herstellung von Cyclopropylamin.
ATE403673T1 (de) Faktor-2 homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition